Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:STML’

Phill Gross of Adage Capital Management

Stemline Therapeutics Inc (STML) Is Burning These Hedge Funds

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the......(read more)
Nathaniel August - Mangrove Partners

Hedge Funds Have Never Been This Bullish On Stemline Therapeutics Inc (STML)

Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (......(read more)
Pressmaster/Shutterstock.com

13G Filing: Adage Capital Management and Stemline Therapeutics Inc (STML)

Stemline Therapeutics Inc (NASDAQ:STML): Phill Gross And Robert Atchinson’s Adage Capital Management filed an amended 13D. You can check out Adage......(read more)
lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Stemline Therapeutics Inc (STML): What’s The Other Side Of The Story?

Stemline Therapeutics Inc (NASDAQ:STML) is one of the biggest stories in the biotechnology space this week. The company has fallen foul of accusations......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Biotech Movers: EnteroMedics Inc (ETRM) And Stemline Therapeutics Inc (STML)

We’re off to a big start for the fresh week in the biotech space, as the lull in volume that generally comes on the back of the holiday period has subsided......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Is Stemline Therapeutics Inc (STML) a Good Stock to Buy?

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of......(read more)
stock, market, business, app, shares, share, news, global, man, phone, big, graph, chart, using, screen, fast, motion, concept, internet, up, tablet, touching, technology,

Here’s Why These Five Stocks Are in Spotlight

U.S. stocks are trading higher ahead of manufacturing data along with new home sales data which is expected tomorrow. Meanwhile oil is trading lower after......(read more)
Juno Therapeutics

JUNO Therapeutics Inc (JUNO); Coherus Biosciences Inc (CHRS), Stemline Therapeutics Inc (STML): VCHP’s Bullish Sentiment Pays Off

Juno Therapeutics Inc (NASDAQ:JUNO) is up by 15% as of Thursday afternoon, following the release of its first-ever earnings report since its IPO. The......(read more)
Steven Cohen of Point72 Asset Management

Second Wave of Moves from SAC Capital

In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes......(read more)
Gogo Inc (NASDAQ:GOGO)

Esperion Therapeutics Inc (ESPR), NanoString Technologies Inc (NSTG) & Gogo Inc (GOGO): Three IPOs That Could Be Tomorrow’s Superstars

Did you miss out on the recent hot IPOs for Noodles & Co (NASDAQ:NDLS), Fairway Group Holdings Corp (NASDAQ:FWM) and Stemline Therapeutics Inc (......(read more)